ICD-10-CM Billable Code

M05.37

Rheumatoid heart disease with rheumatoid arthritis of ankle and foot

Clinical Classification Guidelines

Inclusion Terms

  • Rheumatoid heart disease with rheumatoid arthritis, tarsus, metatarsus and phalanges

Medical Intelligence & Overview

Rheumatoid heart disease, associated with rheumatoid arthritis (RA), affects the heart by causing inflammation and damage to its tissues. When coupled with RA affecting the ankle and foot, it reflects a broader systemic impact of the disease. This condition involves inflammation of the small blood vessels and tissues of the heart, often in association with joint inflammation, particularly in the ankle, tarsus, metatarsus, and phalanges. Recognizing and understanding this complex relationship helps in managing rheumatoid disease more comprehensively.

Causes & Symptoms

Clinical Causes: Autoimmune response characteristic of rheumatoid arthritis, leading to inflammation in joints and other tissues, including the heart. Genetic predisposition that increases susceptibility to RA and related cardiac complications. Environmental factors such as smoking or exposure to certain environmental chemicals that may trigger autoimmune reactions. Prolonged, uncontrolled inflammation from RA can extend beyond joints and involve the heart tissue, leading to rheumatoid heart disease.

Key Symptoms: Persistent joint pain and swelling in the ankles, tarsus, metatarsus, and toes. Fatigue and general malaise due to chronic systemic inflammation. Shortness of breath or chest discomfort if the heart's function becomes compromised. Palpitations or irregular heartbeat in more advanced stages. Signs of heart failure, such as swelling in the legs or abdominal discomfort, in severe cases.

Diagnostic & Treatment

Diagnosis Path: Diagnosing rheumatoid heart disease with RA of the ankle and foot involves a combination of clinical evaluation and diagnostic tests. Healthcare providers typically look for: - Medical history highlighting symptoms of RA and cardiac issues. - Physical examinations of joints and the heart. - Laboratory tests including rheumatoid factor (RF), anti-CCP antibodies, and inflammatory markers such as ESR and CRP. - Imaging studies such as X-rays of the affected joints and echocardiography to assess heart function. - Additional tests like ECG or MRI may be utilized if cardiac involvement is suspected. Prompt diagnosis enables early management to prevent progression.

Treatment Protocols: While treatment may vary based on individual cases, the typical approach includes: - Disease-modifying antirheumatic drugs (DMARDs) like methotrexate to control RA activity. - Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief and inflammation reduction. - Corticosteroids to manage severe inflammation during flare-ups. - Specific therapies targeting heart health, which may include cardiovascular medications. - Lifestyle modifications like regular exercise, a balanced diet, and smoking cessation. - Close monitoring of joint and heart health through ongoing medical evaluations. The goal is to reduce inflammation, preserve joint function, and prevent cardiac complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M05.37 a billable ICD-10 code?
Yes, M05.37 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M05.37?
Clinical documentation must specify the nature of Rheumatoid heart disease with rheumatoid arthritis of ankle and foot and any associated comorbidities for accurate reporting.

Cite this Clinical Reference